Back to search

Histologix Limited

05466753

active
Private Limited Company
england wales
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

BUILDING R3, BIOCITY NOTTINGHAM, NOTTINGHAM, NG1 1GF
Incorporated 28/05/2005

Compliance

Last accounts

30/09/2024

total exemption full

Next accounts due

30/06/2026

On track

Confirmation statement

Last: 11/06/2025

Due 25/06/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Morag Mcfarlane

director · Since 19/09/2018

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 58

Also on 2 other boards

Mr Simon Mark Goulding

director · Since 01/11/2018

CHARTERED ACCOUNTANT

BRITISH · SCOTLAND · Age 60

Also on 2 other boards

Persons with Significant Control

The Niche Cro Group Limited

75–100% shares
75–100% votes
Appoint directors

Ground Floor Fleming Pavillion, Todd Campus, Glasgow, G20 0XA

Reg: Sc692530 · Companies House · Private Limited Company

Notified 08/04/2021

Former PSCs

Mr Andrew Lawrence

Ceased 19/09/2018

Mr David John Fairley

Ceased 10/09/2018

The Intelligent Tissue Group Limited

Ceased 08/04/2021

Charges0 outstanding

charge
satisfied

HSBC BANK PLC

Created 30/06/2005Registered 05/07/2005Satisfied 17/09/2018

CompanyRankvs 51+ SIC 72110 peers
86

Financial strength86th percentile among SIC peers · 22/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 3.27× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
51Histologix Limited
86
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/09/2018

Net Worth

£305k

Balance sheet strength

Cash

£180k

Cash in the bank

Net Current Assets

£223k

Working capital

Current Assets

£321k

Current Liabilities

£98k

Fixed Assets

£189k

Debtors

£115k

Profit After Tax

£27k

14avg. employees

Tax at Year End

Dividends paid£27k

Balance Sheet

Assets less current liabilities£412k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20183.27

Derived from filed accounts. Not audited figures.